01016nas a2200301   4500000000100000008004100001260001300042653001500055653001000070653001000080653001200090653003000102653001100132653001100143653001200154653000900166653002400175653001300199100001300212700001700225700001300242245007300255300001100328490000700339050003200346520032200378022001400700       1988                            d  c1988 Oct10aAdolescent10aAdult10aChild10aDapsone10aDrug Therapy, Combination10aFemale10aHumans10aleprosy10aMale10aProspective Studies10aRifampin1 aGrugni A1 aNadkarni N J1 aKini M S00aMultidrug therapy in paucibacillary leprosy--a five year experience.  a589-920 v60  aInfolep Library - available3 a<p>736 paucibacillary (PB) patients were given multidrug therapy (MDT) for at least 6 months. Overall, 44% became inactive after 6 doses, and 69% after 12 doses. However, 27% remained active at the time of analysis. It is recommended that at least 12 doses of MDT be given to PB patients irrespective of the type.</p>  a0254-9395